Výsledky vyhledávání - Monique Dail

  • Zobrazuji výsledky 1 - 19 z 19
Upřesnit hledání
  1. 1
    EphB Receptor-binding Peptides Identified by Phage Display Enable Design of an Antagonist with Ephrin-like Affinity

    EphB Receptor-binding Peptides Identified by Phage Display Enable Design of an Antagonist with Ephrin-like Affinity Autor Mitchell Koolpe, Rosemary Burgess, Monique Dail, Elena B. Pasquale

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells

    Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells Autor Amit J. Sabnis, Laurene S. Cheung, Monique Dail, Hio Chung Kang, Marianne Santaguida, Michelle L. Hermiston, Emmanuelle Passegué, Kevin Shannon, Benjamin S. Braun

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Mutant <i> Ikzf1, Kras <sup>G12D</sup> </i> , and <i>Notch1</i> cooperate in T lineage leukemogenesis and modulate responses to targeted agents

    Mutant <i> Ikzf1, Kras <sup>G12D</sup> </i> , and <i>Notch1</i> cooperate in T lineage leukemogenesis and modulate responses to targeted agents Autor Monique Dail, Qing Li, Andrew S. McDaniel, Jason W.H. Wong, Keiko Akagi, Benjamin J. Huang, Hio Chung Kang, Scott C. Kogan, Kevan M. Shokat, Linda Wolff, Benjamin S. Braun, Kevin Shannon

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models

    Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models Autor Raghuveer Singh Mali, Qi Zhang, RosaAnna DeFilippis, Antonio Cavazos, Vinitha M. Kuruvilla, Jayant Raman, Vidhi Mody, Edna F. Choo, Monique Dail, Neil P. Shah, Marina Konopleva, Deepak Sampath, Elisabeth A. Lasater

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Outcomes in Patients with Poor-Risk Cytogenetics with or without <i>TP53</i> Mutations Treated with Venetoclax and Azacitidine

    Outcomes in Patients with Poor-Risk Cytogenetics with or without <i>TP53</i> Mutations Treated with Venetoclax and Azacitidine Autor Daniel A. Pollyea, Keith W. Pratz, Andrew H. Wei, Vinod Pullarkat, Brian A. Jonas, Christian Récher, Sunil Babu, Andre C. Schuh, Monique Dail, Yan Sun, Jalaja Potluri, Brenda Chyla, Courtney D. DiNardo

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Impact of <i>F</i> <i>LT3</i> Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia

    Impact of <i>F</i> <i>LT3</i> Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia Autor Marina Konopleva, Michael J. Thirman, Keith W. Pratz, Jacqueline S. Garcia, Christian Récher, Vinod Pullarkat, Hagop M. Kantarjian, Courtney D. DiNardo, Monique Dail, Yinghui Duan, Brenda Chyla, Jalaja Potluri, Catherine L. Miller, Andrew H. Wei

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Venetoclax in Combination with Hypomethylating Agents Induces Rapid, Deep, and Durable Responses in Patients with AML Ineligible for Intensive Therapy

    Venetoclax in Combination with Hypomethylating Agents Induces Rapid, Deep, and Durable Responses in Patients with AML Ineligible for Intensive Therapy Autor Daniel A. Pollyea, Keith W. Pratz, Brian A. Jonas, Anthony Letai, Vinod Pullarkat, Andrew H. Wei, Marina Konopleva, Christian Récher, Olga Frankfurt, David A. Rizzieri, Tu Xu, Monique Dail, Brenda Chyla, Jalaja Potluri, Courtney D. DiNardo

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    ELN Risk Stratification Is Not Predictive of Outcomes for Treatment-Naïve Patients with Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine

    ELN Risk Stratification Is Not Predictive of Outcomes for Treatment-Naïve Patients with Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine Autor Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat, Michael J. Thirman, Christian Récher, Andre C. Schuh, Sunil Babu, Monique Dail, Grace Ku, Yan Sun, Jalaja Potluri, Brenda Chyla, Daniel A. Pollyea

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia

    Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia Autor Monique Dail, Jason W.H. Wong, Jessica Lawrence, Daniel P. O’Connor, Joy Nakitandwe, Shann-Ching Chen, Jin Xu, Leslie B. Lee, Keiko Akagi, Qing Li, Jon C. Aster, Warren S. Pear, James R. Downing, Deepak Sampath, Kevin Shannon

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and <i>IDH1/2</i> Mutations

    Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and <i>IDH1/2</i> Mutations Autor Daniel A. Pollyea, Courtney D. DiNardo, Martha Arellano, Arnaud Pigneux, Walter Fiedler, Marina Konopleva, David A. Rizzieri, B. Douglas Smith, Atsushi Shinagawa, Roberto M. Lemoli, Monique Dail, Yinghui Duan, Brenda Chyla, Jalaja Potluri, Catherine L. Miller, Hagop M. Kantarjian

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis

    Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis Autor Christopher Hartzell, Olga Ksionda, Ed Lemmens, Kristen M. Coakley, Ming Yang, Monique Dail, Richard C. Harvey, Christopher C. Govern, Jeroen Bakker, Tineke L. Lenstra, Kristin Ammon, Anne Boeter, Stuart S. Winter, Mignon L. Loh, Kevin Shannon, Arup K. Chakraborty, Matthias Wabl, Jeroen P. Roose

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma

    Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma Autor Luciano J. Costa, Faith E. Davies, Gregory Monohan, Tibor Kovacsovics, Nicholas Burwick, Andrzej Jakubowiak, Jonathan L. Kaufman, Wan‐Jen Hong, Monique Dail, Ahmed Hamed Salem, Xiaoqing Yang, Abdullah Al Masud, Wijith Munasinghe, Jeremy A. Ross, Orlando F. Bueno, Shaji Kumar, Edward A. Stadtmauer

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine

    Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine Autor Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo, Andrew H. Wei, Brian A. Jonas, Vinod Pullarkat, Michael J. Thirman, Christian Récher, Andre C. Schuh, Sunil Babu, Xiaotong Li, Grace Ku, Zihuan Liu, Yan Sun, Jalaja Potluri, Monique Dail, Brenda Chyla, Daniel A. Pollyea

    Vydáno 2024
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine

    Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine Autor Keith W. Pratz, Brian A. Jonas, Vinod Pullarkat, Christian Récher, Andre C. Schuh, Michael J. Thirman, Jacqueline S. Garcia, Courtney D. DiNardo, Vladimir Vorobyev, Nicola Fracchiolla, Su‐Peng Yeh, Jun Ho Jang, Muhi̇t Özcan, Kazuhito Yamamoto, Árpád Illés, Ying Zhou, Monique Dail, Brenda Chyla, Jalaja Potluri, Hartmut Döhner

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Venetoclax Plus Gilteritinib for <i>FLT3</i>-Mutated Relapsed/Refractory Acute Myeloid Leukemia

    Venetoclax Plus Gilteritinib for <i>FLT3</i>-Mutated Relapsed/Refractory Acute Myeloid Leukemia Autor Naval Daver, Alexander E. Perl, Joseph Maly, Mark J. Levis, Ellen K. Ritchie, Mark R. Litzow, James McCloskey, Catherine C. Smith, Gary J. Schiller, Terrence Bradley, Ramón V. Tiu, Kiran Naqvi, Monique Dail, Deanna J. Brackman, Satya R. Siddani, Jing Wang, Brenda Chyla, Paul Lee, Jessica K. Altman

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

    Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models Autor Lina Han, Qi Zhang, Monique Dail, Ce Shi, Antonio Cavazos, Vivian Ruvolo, Yang Zhao, Eugene S. Kim, Mohamed Rahmani, Duncan H. Mak, Sha Jin, Jun Chen, Darren C. Phillips, Paul Koller, Rodrigo Jácamo, Jared K. Burks, Courtney D. DiNardo, Naval Daver, Elias Jabbour, Jing Wang, Hagop M. Kantarjian, Michael Andreeff, Steven Grant, Joel D. Leverson, Deepak Sampath, Marina Konopleva

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia

    Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia Autor Anica M. Wandler, Benjamin J. Huang, Jeffrey W. Craig, Kathryn Hayes, Hannah H. Yan, Lauren K. Meyer, Alessandro Scacchetti, Gabriela C. Monsalve, Monique Dail, Qing Li, Jasmine C. Wong, Olga K. Weinberg, Robert P. Hasserjian, Scott C. Kogan, Philip Jonsson, Keith R. Yamamoto, Deepak Sampath, Joy Nakitandwe, James R. Downing, Jinghui Zhang, Jon C. Aster, Barry S. Taylor, Kevin Shannon

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

    Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial Autor Naval Daver, Monique Dail, Jacqueline S. Garcia, Brian A. Jonas, Karen Yee, Kevin R. Kelly, Norbert Vey, Sarit Assouline, Gail J. Roboz, Stefania Paolini, Daniel A. Pollyea, Agostino Tafuri, Joseph Brandwein, Arnaud Pigneux, Bayard L. Powell, Pierre Fenaux, Rebecca L. Olin, Giuseppe Visani, Giovanni Martinelli, Maika Onishi, Jue Wang, Weize Huang, Cherie Green, Marion Ott, Wan‐Jen Hong, Marina Konopleva, Michael Andreeff

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance

    RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance Autor Vanessa E. Kennedy, Cheryl A.C. Peretz, Anushka Walia, Brenda Chyla, Yan Sun, Jason E. Hill, Elaine Tran, Andrew Koh, Timothy T. Ferng, Samantha M. Pintar, Matthew F. Jones, Bogdan Popescu, Natália Faraj Murad, Ritu Roy, Adam B. Olshen, Sunil Joshi, Elie Traer, Monique Dail, Habib Hamidi, Jessica K. Altman, Naval Daver, Mark J. Levis, James McCloskey, Alexander E. Perl, Catherine C. Smith

    Vydáno 2025
    Získat plný text
    Pré-impressão
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: